Comprehensive Evaluation of Ischemic Heart Disease Using MRI

NCT01234870 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Heart Disease, Ischemic
Atherosclerosis, Coronary

Interventions

DRUG: Gadolinium
DRUG: Adenosine

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]